Shopping Cart 0
Cart Subtotal
USD 0

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 17

2 Introduction 18

2.1 Colorectal Cancer Diagnostic Tests Overview 18

3 Products under Development 19

3.1 Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 19

3.2 Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 20

3.3 Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 21

3.4 Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 22

3.5 Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 23

4 Colorectal Cancer Diagnostic Tests-Pipeline Products under Development by Companies 24

4.1 Colorectal Cancer Companies-Pipeline Products by Stage of Development 24

4.2 Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 29

5 Colorectal Cancer Diagnostic Tests Companies and Product Overview 33

5.1 2cureX AB Company Overview 33

5.2 Abcodia Ltd Company Overview 36

5.3 Advanced Marker Discovery SL Company Overview 37

5.4 Advpharma Inc Company Overview 38

5.5 Almac Diagnostics Ltd Company Overview 39

5.6 Ambergen Inc Company Overview 40

5.7 ANGLE plc Company Overview 41

5.8 Applied Proteomics Inc Company Overview 42

5.9 Arizona State University Company Overview 43

5.10 ArtemixRx Company Overview 44

5.11 Avant Diagnostics, Inc. Company Overview 45

5.12 Bio Mark Ltd Company Overview 46

5.13 Biodesix Inc Company Overview 47

5.14 BioMarCare Technologies Ltd Company Overview 48

5.15 BioMark Diagnostics Inc. Company Overview 49

5.16 BioMarker Strategies LLC Company Overview 50

5.17 bioMerieux SA Company Overview 51

5.18 Biomoda Inc Company Overview 52

5.19 Bioprognos SL Company Overview 53

5.20 BioSystems International Company Overview 54

5.21 BioTime Inc Company Overview 55

5.22 Biotron Ltd Company Overview 56

5.23 Castle Biosciences Inc Company Overview 57

5.24 Catholic University of Leuven Company Overview 58

5.25 Celcuity LLC Company Overview 59

5.26 CellMax Life Inc Company Overview 60

5.27 Cellmid Ltd Company Overview 61

5.28 Ceres Nanosciences Inc Company Overview 63

5.29 Cernostics Inc Company Overview 64

5.30 ChemImage Corp Company Overview 65

5.31 China Sky One Medical Inc Company Overview 66

5.32 Columbia University Company Overview 67

5.33 CS-Keys, Inc. (Inactive) Company Overview 68

5.34 Di.V.A.L Toscana srl Company Overview 69

5.35 DiagnoCure Inc. (Inactive) Company Overview 70

5.36 Diaxonhit SA Company Overview 72

5.37 Diazyme Laboratories Inc Company Overview 73

5.38 DNAlytics Company Overview 74

5.39 EDP Biotech Corporation Company Overview 77

5.40 Epigenomics AG Company Overview 78

5.41 Eventus Diagnostics Inc (Inactive) Company Overview 80

5.42 Exact Sciences Corp Company Overview 81

5.43 Exiqon A/S Company Overview 82

5.44 Exosomics Siena SpA Company Overview 83

5.45 Fina Biotech SL Company Overview 84

5.46 Fox Chase Cancer Center Company Overview 85

5.47 GenomicTree Inc Company Overview 86

5.48 German Cancer Research Center Company Overview 88

5.49 Ghent University Company Overview 90

5.50 GlycoZym Company Overview 91

5.51 Health Discovery Corp Company Overview 92

5.52 Hitachi Ltd Company Overview 93

5.53 Human Metabolome Technologies Inc Company Overview 94

5.54 Ikonisys Inc Company Overview 95

5.55 Institute of Molecular and Translational Medicine Company Overview 96

5.56 InterGenetics Inc Company Overview 97

5.57 IV Diagnostics Inc Company Overview 98

5.58 Johns Hopkins University Company Overview 99

5.59 King Abdullah University of Science and Technology Company Overview 101

5.60 Kyo Diagnostics KK Company Overview 102

5.61 Lab21 Ltd Company Overview 103

5.62 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 104

5.63 Leitat Technological Center Company Overview 105

5.64 Lightsphere Diagnostics Company Overview 107

5.65 MabCure Inc. Company Overview 108

5.66 Master Diagnostica Sociedad Limitada Company Overview 109

5.67 Matrix-Bio, Inc. Company Overview 110

5.68 Max Delbruck Center for Molecular Medicine Company Overview 113

5.69 Mayo Clinic Company Overview 114

5.70 MDNA Life Sciences Inc Company Overview 115

5.71 MDxHealth SA Company Overview 116

5.72 Merrimack Pharmaceuticals Inc Company Overview 118

5.73 Metabiomics Corporation Company Overview 119

5.74 Metabolon Inc Company Overview 121

5.75 MetaStat Inc Company Overview 122

5.76 Milagen Inc Company Overview 123

5.77 Myriad Genetics Inc Company Overview 124

5.78 Nanocytomics LLC Company Overview 125

5.79 Natera Inc Company Overview 126

5.80 Norda ASA Company Overview 127

5.81 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 128

5.82 Nuclea Biotechnologies Inc. (Inactive) Company Overview 129

5.83 Oncimmune (USA) LLC Company Overview 130

5.84 Onconome, Inc. (Inactive) Company Overview 131

5.85 OncoStem Diagnostics Pvt. Ltd Company Overview 132

5.86 On-Q-ity, Inc. (Inactive) Company Overview 133

5.87 Origin Sciences Ltd Company Overview 134

5.88 Orion Genomics LLC Company Overview 135

5.89 OTraces Inc. Company Overview 136

5.90 Oxford Cancer Biomarkers Ltd Company Overview 137

5.91 Oxford Gene Technology Ltd Company Overview 138

5.92 PleX Diagnostics Inc (Inactive) Company Overview 139

5.93 Precision Biologics Inc Company Overview 140

5.94 Prediction Sciences LLC (Inactive) Company Overview 141

5.95 PreMD Inc (Inactive) Company Overview 142

5.96 Protagen AG Company Overview 143

5.97 Protein Alternatives SL Company Overview 144

5.98 Qiagen NV Company Overview 145

5.99 Quest Diagnostics Inc Company Overview 146

5.100 Rabin Medical Center Company Overview 147

5.101 Rhythm Biosciences Ltd Company Overview 148

5.102 RISE Life Science Corp Company Overview 149

5.103 Rna Diagnostics Inc Company Overview 150

5.104 Rosetta Genomics Ltd Company Overview 151

5.105 Scienion AG Company Overview 152

5.106 Seegene Inc Company Overview 153

5.107 Shuwen Biotech Co Ltd Company Overview 154

5.108 Sysmex Corp Company Overview 155

5.109 Tel Aviv University Company Overview 156

5.110 The Chinese University of Hong Kong Company Overview 157

5.111 The Walter and Eliza Hall Institute of Medical Research Company Overview 158

5.112 TheraDiag SA Company Overview 159

5.113 Treos Bio Inc Company Overview 161

5.114 Trinity College Dublin Company Overview 162

5.115 Universal Diagnostics SL Company Overview 163

5.116 University of Illinois at Chicago Company Overview 164

5.117 University of Lyon Company Overview 165

5.118 University of Michigan Company Overview 166

5.119 University of Notre Dame Company Overview 167

5.120 University of Pittsburgh Company Overview 168

5.121 University of Texas MD Anderson Cancer Center Company Overview 171

5.122 University of Turku Company Overview 172

5.123 University of Washington Company Overview 173

5.124 University of Wisconsin Madison Company Overview 174

5.125 US Biomarkers Inc Company Overview 175

5.126 vall d hebron institut de Recerca Company Overview 176

5.127 Vanderbilt University Company Overview 178

5.128 Viomics Inc. Company Overview 180

5.129 VolitionRX Ltd Company Overview 181

5.130 XEPTAGEN SpA Company Overview 191

6 Colorectal Cancer Diagnostic Tests-Recent Developments 192

6.1 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 192

6.2 Jun 29, 2018: GeneNews Announces Directors Election 192

6.3 Jun 21, 2018: 2cureX presents positive clinical data from its IndiTreat CRC trial at ESMO in Barcelona 193

6.4 Jun 21, 2018: Rhythm Biosciences completes cloning step of key reagent development ahead of schedule 193

6.5 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 194

6.6 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 195

6.7 Jun 19, 2018: Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer 195

6.8 Jun 19, 2018: Polymedco Announces Updated American Cancer Society Guidelines for Colorectal Cancer Screening 196

6.9 Jun 13, 2018: Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals 197

6.10 Jun 13, 2018: Vermillion Appoints Chris Goulart As Senior Vice President Of Commercial Operations 198

6.11 Jun 12, 2018: OGT expands custom NGS cancer panel content 198

6.12 Jun 07, 2018: CENTOGENE Partners with the Universities of Greifswald and Rostock to Develop Fast-Tracked Diagnostic Workflow for Personalized Immune-based Therapies for Colon and Pancreatic Tumors 199

6.13 Jun 05, 2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors 199

6.14 Jun 01, 2018: Gopath Labs Announces North American Launch of MiR-31-3p Expression Test 200

6.15 Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 200

7 Appendix 399

7.1 Methodology 399

7.2 About GlobalData 402

7.3 Contact Us 402

7.4 Disclaimer 402


List Of Figure

1.2 List of Figures

Figure 1: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 22

Figure 2: Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 23

Figure 3: Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 24

Figure 4: Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 25

Figure 5: Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 26


List Of Table

1.1 List of Tables

Table 1: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 22

Table 2: Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 23

Table 3: Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 24

Table 4: Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 25

Table 5: Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 26

Table 6: Colorectal Cancer Companies-Pipeline Products by Stage of Development 27

Table 7: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 32

Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview 36

Table 9: IndiTreat-CRC-Product Status 36

Table 10: IndiTreat-CRC-Product Description 36

Table 11: 2cureX AB-Ongoing Clinical Trials Overview 37

Table 12: IndiTreat-CRC-Clinical Evaluation of IndiTreat test for Patients with Stage IV Colorectal Cancer 38

Table 13: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 14: Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 39

Table 15: Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 39

Table 16: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 40

Table 17: ColoFast-Product Status 40

Table 18: ColoFast-Product Description 40

Table 19: Advpharma Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 20: Molecular Diagnostic Biomarker-Colorectal Cancer Diagnostic Tests-Product Status 41

Table 21: Molecular Diagnostic Biomarker-Colorectal Cancer Diagnostic Tests-Product Description 41

Table 22: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

Table 23: DNA Damage Response Deficiency Assay-Colorectal Cancer Diagnostic Tests-Product Status 42

Table 24: DNA Damage Response Deficiency Assay-Colorectal Cancer Diagnostic Tests-Product Description 42

Table 25: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 26: Veracode-Colorectal Cancer Diagnostic Tests-Product Status 43

Table 27: Veracode-Colorectal Cancer Diagnostic Tests-Product Description 43

Table 28: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 29: Parsortix-Based Test-Colorectal Cancer Diagnostic Tests-Product Status 44

Table 30: Parsortix-Based Test-Colorectal Cancer Diagnostic Tests-Product Description 44

Table 31: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 32: SimpliPro Colon-A-Product Status 45

Table 33: SimpliPro Colon-A-Product Description 45

Table 34: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 46

Table 35: Biomarker Test-Colorectal Cancer Diagnostic Tests-Product Status 46

Table 36: Biomarker Test-Colorectal Cancer Diagnostic Tests-Product Description 46

Table 37: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 47

Table 38: ArtemixRx Prognostic Test-Colon Cancer-Product Status 47

Table 39: ArtemixRx Prognostic Test-Colon Cancer-Product Description 47

Table 40: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 41: TheraLink Assay-Colorectal Cancer Diagnostic Tests-Product Status 48

Table 42: TheraLink Assay-Colorectal Cancer Diagnostic Tests-Product Description 48

Table 43: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Table 44: Diagnostic Test-Colorectal Adenoma-Product Status 49

Table 45: Diagnostic Test-Colorectal Adenoma-Product Description 49

Table 46: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Table 47: VeriStrat-Colorectal Cancer Diagnostic Tests-Product Status 50

Table 48: VeriStrat-Colorectal Cancer Diagnostic Tests-Product Description 50

Table 49: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 50: mCRC-Strat-Product Status 51

Table 51: mCRC-Strat-Product Description 51

Table 52: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

Table 53: Metabolomics-based Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 52

Table 54: Metabolomics-based Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 52

Table 55: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 53

Table 56: Ex Vivo Biomarker Test-Colon Cancer-Product Status 53

Table 57: Ex Vivo Biomarker Test-Colon Cancer-Product Description 53

Table 58: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 54

Table 59: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Status 54

Table 60: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Description 54

Table 61: Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Table 62: CyPath Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 55

Table 63: CyPath Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 55

Table 64: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 56

Table 65: MBDAA Colorectal Cancer Test-Product Status 56

Table 66: MBDAA Colorectal Cancer Test-Product Description 56

Table 67: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 57

Table 68: Diagnostic Test-Colon Cancer-Product Status 57

Table 69: Diagnostic Test-Colon Cancer-Product Description 57

Table 70: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 71: PanC-Dx-Colon Cancer-Product Status 58

Table 72: PanC-Dx-Colon Cancer-Product Description 58

Table 73: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Table 74: C-Test-Colorectal Cancer Diagnostic Tests-Product Status 59

Table 75: C-Test-Colorectal Cancer Diagnostic Tests-Product Description 59

Table 76: Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Table 77: DecisionDx-Rectal Cancer-Product Status 60

Table 78: DecisionDx-Rectal Cancer-Product Description 60

Table 79: Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview 61

Table 80: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Status 61

Table 81: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Description 61

Table 82: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview 62

Table 83: CELx Test-Colon Cancer-Product Status 62

Table 84: CELx Test-Colon Cancer-Product Description 62

Table 85: CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 86: CellMax Monitor-Colorectal Cancer Diagnostic Tests-Product Status 63

Table 87: CellMax Monitor-Colorectal Cancer Diagnostic Tests-Product Description 63

Table 88: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Table 89: MK-ELISA Assay-Colorectal Cancer Diagnostic Tests-Product Status 64

Table 90: MK-ELISA Assay-Colorectal Cancer Diagnostic Tests-Product Description 64

Table 91: MK-ELISA Assay-Metastatic Colorectal Cancer Diagnostic Tests-Product Status 65

Table 92: MK-ELISA Assay-Metastatic Colorectal Cancer Diagnostic Tests-Product Description 65

Table 93: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Table 94: Nanotrap Colon Cancer Biomarker Test-Product Status 66

Table 95: Nanotrap Colon Cancer Biomarker Test-Product Description 66

Table 96: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Table 97: TissueCypher Colon Cancer Test-Product Status 67

Table 98: TissueCypher Colon Cancer Test-Product Description 67

Table 99: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 68

Table 100: Raman Assay-Colorectal Cancer Diagnostic Tests-Product Status 68

Table 101: Raman Assay-Colorectal Cancer Diagnostic Tests-Product Description 68

Table 102: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Table 103: Diagnostic Kit-Rectum Cancer-Product Status 69

Table 104: Diagnostic Kit-Rectum Cancer-Product Description 69

Table 105: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 70

Table 106: IGFBP-3 Diagnostic Test-Product Status 70

Table 107: IGFBP-3 Diagnostic Test-Product Description 70

Table 108: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

Table 109: caPCNA Test-Colorectal Cancer Diagnostic Tests-Product Status 71

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

2cureX AB, IndiTreat - CRC; Abcodia Ltd, Diagnostic Assay - Colorectal Cancer; Advanced Marker Discovery SL, ColoFast; Advpharma Inc, Molecular Diagnostic Biomarker - Colorectal Cancer; Almac Diagnostics Ltd, DNA Damage Response Deficiency Assay - Colorectal Cancer; Ambergen Inc, Veracode - Colorectal Cancer; ANGLE plc, Parsortix-Based Test - Colorectal Cancer; Applied Proteomics Inc, SimpliPro Colon-A; Arizona State University, Biomarker Test - Colorectal Cancer; ArtemixRx, ArtemixRx Prognostic Test - Colon Cancer; Avant Diagnostics, Inc., TheraLink Assay - Colorectal Cancer; Bio Mark Ltd, Diagnostic Test - Colorectal Adenoma; Biodesix Inc, VeriStrat - Colorectal Cancer; BioMarCare Technologies Ltd, mCRC-Strat; BioMark Diagnostics Inc., Metabolomics-based Diagnostic Assay - Colorectal Cancer; BioMarker Strategies LLC, Ex Vivo Biomarker Test - Colon Cancer; bioMerieux SA, Diagnostic Test - Colorectal Cancer; Biomoda Inc, CyPath Diagnostic Assay - Colorectal Cancer; Bioprognos SL, MBDAA Colorectal Cancer Test; BioSystems International, Diagnostic Test - Colon Cancer; BioTime Inc, PanC-Dx - Colon Cancer; Biotron Ltd, C-Test - Colorectal Cancer; Castle Biosciences Inc, DecisionDx - Rectal Cancer; Catholic University of Leuven, Diagnostic Test - Colorectal Cancer; Celcuity LLC, CELx Test - Colon Cancer; CellMax Life Inc, CellMax Monitor - Colorectal Cancer; Cellmid Ltd, MK-ELISA Assay - Colorectal Cancer; Cellmid Ltd, MK-ELISA Assay - Metastatic Colorectal Cancer; Ceres Nanosciences Inc, Nanotrap Colon Cancer Biomarker Test; Cernostics Inc, TissueCypher Colon Cancer Test; ChemImage Corp, Raman Assay - Colorectal Cancer; China Sky One Medical Inc, Diagnostic Kit - Rectum Cancer; Columbia University, IGFBP-3 Diagnostic Test; CS-Keys, Inc. (Inactive), caPCNA Test - Colorectal Cancer; Di.V.A.L Toscana srl , NanoMabKv - Colorectal Cancer; DiagnoCure Inc. (Inactive), Colorectal/GCC Monitoring Test; DiagnoCure Inc. (Inactive), Colorectal/Shc Prognostic Test; Diaxonhit SA, EHT Dx 12; Diazyme Laboratories Inc, TRAIL-R2 Assay; DNAlytics, ColonoKit; EDP Biotech Corporation, ColoMarker Assay; Epigenomics AG, Diagnostic Test - Colorectal Cancer; Epigenomics AG, Epi proColon 1.0; Eventus Diagnostics Inc (Inactive), Octava Test - Colon Cancer; Exact Sciences Corp, PreGen-Plus; Exiqon A/S, Colon Cancer Test - Stage III And IV Patient; Exosomics Siena SpA, ExoTEST Colorectal; Fina Biotech SL, Dx Bioenergetic Signature - Colon Cancer; Fox Chase Cancer Center, Prognostic Marker - Colorectal Cancer; GenomicTree Inc, EarlyTect Colon Cancer; GenomicTree Inc, EarlyTect Colorectal Cancer - Recurrence; German Cancer Research Center, Autoantibody Panel - Colorectal Cancer; German Cancer Research Center, Biomarker Panel - Colorectal Cancer; Ghent University, Biomarker Test - Colorectal Cancer; GlycoZym, Diagnostic Assay - Colon Cancer; Health Discovery Corp, Diagnostic Test - Colon Cancer; Hitachi Ltd, Urine Based Diagnostic Test - Colon Cancer; Human Metabolome Technologies Inc, Biomarker Based Assay - Colorectal Cancer; Ikonisys Inc, oncoFISH colorectal; Institute of Molecular and Translational Medicine, Diagnostic Biomarker - Colorectal Cancer; InterGenetics Inc, OncoVue Colon; IV Diagnostics Inc, Diagnostic Assay - Colon Cancer; Johns Hopkins University, 5hmC Based Diagnostic Tool - Cancer; Johns Hopkins University, mRNA Biomarker - Colon Cancer; Johns Hopkins University, Prognosis Test - Colorectal Cancer; King Abdullah University of Science and Technology, Diagnostic Test - Colorectal Cancer; Kyo Diagnostics KK, Diagnostic Test - Colorectal Cancer; Lab21 Ltd, Onconostica; Laboratorios Alpha San Ignacio Pharma S.L., OncoSafe; Leitat Technological Center, ELISA Kit - S100A4 - Colon Cancer; Leitat Technological Center, ELISA Kit - S100P - Colon Cancer; Lightsphere Diagnostics, RACC Test - Colorectal Cancer; MabCure Inc., Diagnostic Test - Colorectal Cancer; Master Diagnostica Sociedad Limitada, KRAS / NRAS / BRAF Mutation Flow Chip Test - Colon Cancer; Matrix-Bio, Inc., Companion Diagnostic Test - Colon Cancer; Matrix-Bio, Inc., VeraMarker CCM Test; Matrix-Bio, Inc., VeraMarker CCS Test; Max Delbruck Center for Molecular Medicine, Companion Diagnostic Assay - Colorectal Cancer; Mayo Clinic, Blood Test - Colon Cancer; MDNA Life Sciences Inc, Diagnostic Test - Colorectal Cancer; MDxHealth SA, InformMDx - Colon Cancer; MDxHealth SA, PredictMDx - Colon Cancer; Merrimack Pharmaceuticals Inc, MM-151 Companion Diagnostic Assay - Colorectal Cancer; Metabiomics Corporation, Microbiome Biomarker Screening Test - Colorectal Cancer; Metabiomics Corporation, Microbiome Biomarker Screening Test - Precancerous Colon Polyps; Metabolon Inc, Diagnostic Test - Colorectal Cancer; MetaStat Inc, MenaCalc Colorectal; Milagen Inc, Immunoassay - Colon Cancer; Myriad Genetics Inc, Diagnostic Test - Colon Cancer; Nanocytomics LLC, Minimally Intrusive Fecal Test - Colorectal Cancer; Natera Inc, Signatera - Colorectal Cancer; Norda ASA, Genefec III; Novel Bio-spectrum Technologies Inc (Inactive), NBT Diagnostic Test - Colon Cancer; Nuclea Biotechnologies Inc. (Inactive), Colon Cancer Recurrence Diagnostic Test; Oncimmune (USA) LLC, EarlyCDT - Colon Cancer; Onconome, Inc. (Inactive), ColoMark CCSA-4 Serum Assay; OncoStem Diagnostics Pvt. Ltd, CanAssist - Colon Cancer; On-Q-ity, Inc. (Inactive), Dual-Capture Microfluidic Chip - Colon Cancer; Origin Sciences Ltd, CRC Test; Orion Genomics LLC, Orion CRC Risk Test; OTraces Inc., Colon Cancer Sera Dx; Oxford Cancer Biomarkers Ltd, ColoNav; Oxford Gene Technology Ltd, Diagnostic Assay - Colorectal Cancer; PleX Diagnostics Inc (Inactive), Diagnostic Assay - Colorectal Cancer; Precision Biologics Inc, Diagnostic Assay - Colorectal Cancer; Prediction Sciences LLC (Inactive), GeneRx Colorectal Cancer Profile; PreMD Inc (Inactive), Colopath/ColorectAlert; Protagen AG, Diagnostic Assay - Colon Cancer; Protein Alternatives SL, Colorectal Cancer Diagnostic Kit; Qiagen NV, Blood Based Test - Colorectal Cancer; Quest Diagnostics Inc, Diagnostic Assay - Colorectal Cancer; Rabin Medical Center, Diagnostic Test - Colon Cancer; Rhythm Biosciences Ltd, ColoSTAT; RISE Life Science Corp, Diagnostic Test - Colorectal Cancer; Rna Diagnostics Inc, RNA Disruption Assay - Rectal Cancer; Rosetta Genomics Ltd, miRscreen Test - Colon Cancer; Scienion AG, Diagnostic Test - Colon Cancer; Seegene Inc, MDx - Colon Cancer; Shuwen Biotech Co Ltd, Colorectal Cancer Theranostic Test; Sysmex Corp, Methylated DNA Colon Cancer Diagnostic Test; Tel Aviv University, Biomarker-Based Diagnostic Kit - Colorectal Cancer; The Chinese University of Hong Kong, Colorectal Cancer Screening Tool; The Walter and Eliza Hall Institute of Medical Research, Blood-Based Screening Test - Colon Cancer; TheraDiag SA, Non-invasive Theranostics Test - Metastatic Recurrence; TheraDiag SA, Non-invasive Theranostics Test - Radiochemotherapy; Treos Bio Inc, PolyPEPI 1015 CDx; Trinity College Dublin, Biomarker Test - Colorectal Cancer; Universal Diagnostics SL, Blood Based Diagnostic Test - Colorectal Cancer; University of Illinois at Chicago, Diagnostic Test - Colorectal Cancer; University of Lyon, Biomarker Prognostic Test - Colon Cancer; University of Michigan, Peptide Biomarker Test - Colorectal Cancer; University of Notre Dame, Biomarker Test - Colon Cancer; University of Pittsburgh, Biomarker Test - Colorectal Cancer; University of Texas MD Anderson Cancer Center, Biomarker Based Assay - Colorectal Neoplasia; University of Turku, Lectin-Nanoparticle Biomarker - Colorectal Cancer; University of Washington, Biomarker - Colon Cancer; University of Wisconsin Madison, Diagnostic Kit - Colon Cancer; US Biomarkers Inc, Blood-Based Biomarker - Colorectal Cancer; vall d hebron institut de Recerca , Aprataxin Biomarker - Colorectal Cancer; vall d hebron institut de Recerca , Companion Diagnostic Assay - Colon Cancer; Vanderbilt University, Diagnostic Test - High-Risk Stage II Colorectal Cancer; Vanderbilt University, VICC Blood-Based Diagnostic Test - Colorectal Cancer; Viomics Inc., Viomics Diagnostic Assay - Colon Cancer; VolitionRX Ltd, Nu.Q CRC Screening Test; VolitionRX Ltd, Nu.Q CRC Symptomatic Test; VolitionRX Ltd, Nu.Q CRC Triage Test; VolitionRX Ltd, Nu.Q Frontline Asymptomatic CRC Screening Test; VolitionRX Ltd, NuQ T003 Assay - Colorectal Cancer; VolitionRX Ltd, NuQ V001 Assay - Colorectal Cancer; VolitionRX Ltd, NuQ X001S Assay - Colorectal Cancer; XEPTAGEN SpA, CA19.9 - IgM Kit


Companies

2cureX AB

Abcodia Ltd

Advanced Marker Discovery SL

Advpharma Inc

Almac Diagnostics Ltd

Ambergen Inc

ANGLE plc

Applied Proteomics Inc

Arizona State University

ArtemixRx

Avant Diagnostics, Inc.

Bio Mark Ltd

Biodesix Inc

BioMarCare Technologies Ltd

BioMark Diagnostics Inc.

BioMarker Strategies LLC

bioMerieux SA

Biomoda Inc

Bioprognos SL

BioSystems International

BioTime Inc

Biotron Ltd

Castle Biosciences Inc

Catholic University of Leuven

Celcuity LLC

CellMax Life Inc

Cellmid Ltd

Ceres Nanosciences Inc

Cernostics Inc

ChemImage Corp

China Sky One Medical Inc

Columbia University

CS-Keys, Inc.

Di.V.A.L Toscana srl

DiagnoCure Inc.

Diaxonhit SA

Diazyme Laboratories Inc

DNAlytics

EDP Biotech Corporation

Epigenomics AG

Eventus Diagnostics Inc

Exact Sciences Corp

Exiqon A/S

Exosomics Siena SpA

Fina Biotech SL

Fox Chase Cancer Center

GenomicTree Inc

German Cancer Research Center

Ghent University

GlycoZym

Health Discovery Corp

Hitachi Ltd

Human Metabolome Technologies Inc

Ikonisys Inc

Institute of Molecular and Translational Medicine

InterGenetics Inc

IV Diagnostics Inc

Johns Hopkins University

King Abdullah University of Science and Technology

Kyo Diagnostics KK

Lab21 Ltd

Laboratorios Alpha San Ignacio Pharma S.L.

Leitat Technological Center

Lightsphere Diagnostics

MabCure Inc.

Master Diagnostica Sociedad Limitada

Matrix-Bio, Inc.

Max Delbruck Center for Molecular Medicine

Mayo Clinic

MDNA Life Sciences Inc

MDxHealth SA

Merrimack Pharmaceuticals Inc

Metabiomics Corporation

Metabolon Inc

MetaStat Inc

Milagen Inc

Myriad Genetics Inc

Nanocytomics LLC

Natera Inc

Norda ASA

Novel Bio-spectrum Technologies Inc

Nuclea Biotechnologies Inc.

Oncimmune (USA) LLC

Onconome, Inc.

OncoStem Diagnostics Pvt. Ltd

On-Q-ity, Inc.

Origin Sciences Ltd

Orion Genomics LLC

OTraces Inc.

Oxford Cancer Biomarkers Ltd

Oxford Gene Technology Ltd

PleX Diagnostics Inc

Precision Biologics Inc

Prediction Sciences LLC

PreMD Inc

Protagen AG

Protein Alternatives SL

Qiagen NV

Quest Diagnostics Inc

Rabin Medical Center

Rhythm Biosciences Ltd

RISE Life Science Corp

Rna Diagnostics Inc

Rosetta Genomics Ltd

Scienion AG

Seegene Inc

Shuwen Biotech Co Ltd

Sysmex Corp

Tel Aviv University

The Chinese University of Hong Kong

The Walter and Eliza Hall Institute of Medical Research

TheraDiag SA

Treos Bio Inc

Trinity College Dublin

Universal Diagnostics SL

University of Illinois at Chicago

University of Lyon

University of Michigan

University of Notre Dame

University of Pittsburgh

University of Texas MD Anderson Cancer Center

University of Turku

University of Washington

University of Wisconsin Madison

US Biomarkers Inc

vall d hebron institut de Recerca

Vanderbilt University

Viomics Inc.

VolitionRX Ltd

XEPTAGEN SpA

Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 17

2 Introduction 18

2.1 Colorectal Cancer Diagnostic Tests Overview 18

3 Products under Development 19

3.1 Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 19

3.2 Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 20

3.3 Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 21

3.4 Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 22

3.5 Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 23

4 Colorectal Cancer Diagnostic Tests-Pipeline Products under Development by Companies 24

4.1 Colorectal Cancer Companies-Pipeline Products by Stage of Development 24

4.2 Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 29

5 Colorectal Cancer Diagnostic Tests Companies and Product Overview 33

5.1 2cureX AB Company Overview 33

5.2 Abcodia Ltd Company Overview 36

5.3 Advanced Marker Discovery SL Company Overview 37

5.4 Advpharma Inc Company Overview 38

5.5 Almac Diagnostics Ltd Company Overview 39

5.6 Ambergen Inc Company Overview 40

5.7 ANGLE plc Company Overview 41

5.8 Applied Proteomics Inc Company Overview 42

5.9 Arizona State University Company Overview 43

5.10 ArtemixRx Company Overview 44

5.11 Avant Diagnostics, Inc. Company Overview 45

5.12 Bio Mark Ltd Company Overview 46

5.13 Biodesix Inc Company Overview 47

5.14 BioMarCare Technologies Ltd Company Overview 48

5.15 BioMark Diagnostics Inc. Company Overview 49

5.16 BioMarker Strategies LLC Company Overview 50

5.17 bioMerieux SA Company Overview 51

5.18 Biomoda Inc Company Overview 52

5.19 Bioprognos SL Company Overview 53

5.20 BioSystems International Company Overview 54

5.21 BioTime Inc Company Overview 55

5.22 Biotron Ltd Company Overview 56

5.23 Castle Biosciences Inc Company Overview 57

5.24 Catholic University of Leuven Company Overview 58

5.25 Celcuity LLC Company Overview 59

5.26 CellMax Life Inc Company Overview 60

5.27 Cellmid Ltd Company Overview 61

5.28 Ceres Nanosciences Inc Company Overview 63

5.29 Cernostics Inc Company Overview 64

5.30 ChemImage Corp Company Overview 65

5.31 China Sky One Medical Inc Company Overview 66

5.32 Columbia University Company Overview 67

5.33 CS-Keys, Inc. (Inactive) Company Overview 68

5.34 Di.V.A.L Toscana srl Company Overview 69

5.35 DiagnoCure Inc. (Inactive) Company Overview 70

5.36 Diaxonhit SA Company Overview 72

5.37 Diazyme Laboratories Inc Company Overview 73

5.38 DNAlytics Company Overview 74

5.39 EDP Biotech Corporation Company Overview 77

5.40 Epigenomics AG Company Overview 78

5.41 Eventus Diagnostics Inc (Inactive) Company Overview 80

5.42 Exact Sciences Corp Company Overview 81

5.43 Exiqon A/S Company Overview 82

5.44 Exosomics Siena SpA Company Overview 83

5.45 Fina Biotech SL Company Overview 84

5.46 Fox Chase Cancer Center Company Overview 85

5.47 GenomicTree Inc Company Overview 86

5.48 German Cancer Research Center Company Overview 88

5.49 Ghent University Company Overview 90

5.50 GlycoZym Company Overview 91

5.51 Health Discovery Corp Company Overview 92

5.52 Hitachi Ltd Company Overview 93

5.53 Human Metabolome Technologies Inc Company Overview 94

5.54 Ikonisys Inc Company Overview 95

5.55 Institute of Molecular and Translational Medicine Company Overview 96

5.56 InterGenetics Inc Company Overview 97

5.57 IV Diagnostics Inc Company Overview 98

5.58 Johns Hopkins University Company Overview 99

5.59 King Abdullah University of Science and Technology Company Overview 101

5.60 Kyo Diagnostics KK Company Overview 102

5.61 Lab21 Ltd Company Overview 103

5.62 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 104

5.63 Leitat Technological Center Company Overview 105

5.64 Lightsphere Diagnostics Company Overview 107

5.65 MabCure Inc. Company Overview 108

5.66 Master Diagnostica Sociedad Limitada Company Overview 109

5.67 Matrix-Bio, Inc. Company Overview 110

5.68 Max Delbruck Center for Molecular Medicine Company Overview 113

5.69 Mayo Clinic Company Overview 114

5.70 MDNA Life Sciences Inc Company Overview 115

5.71 MDxHealth SA Company Overview 116

5.72 Merrimack Pharmaceuticals Inc Company Overview 118

5.73 Metabiomics Corporation Company Overview 119

5.74 Metabolon Inc Company Overview 121

5.75 MetaStat Inc Company Overview 122

5.76 Milagen Inc Company Overview 123

5.77 Myriad Genetics Inc Company Overview 124

5.78 Nanocytomics LLC Company Overview 125

5.79 Natera Inc Company Overview 126

5.80 Norda ASA Company Overview 127

5.81 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 128

5.82 Nuclea Biotechnologies Inc. (Inactive) Company Overview 129

5.83 Oncimmune (USA) LLC Company Overview 130

5.84 Onconome, Inc. (Inactive) Company Overview 131

5.85 OncoStem Diagnostics Pvt. Ltd Company Overview 132

5.86 On-Q-ity, Inc. (Inactive) Company Overview 133

5.87 Origin Sciences Ltd Company Overview 134

5.88 Orion Genomics LLC Company Overview 135

5.89 OTraces Inc. Company Overview 136

5.90 Oxford Cancer Biomarkers Ltd Company Overview 137

5.91 Oxford Gene Technology Ltd Company Overview 138

5.92 PleX Diagnostics Inc (Inactive) Company Overview 139

5.93 Precision Biologics Inc Company Overview 140

5.94 Prediction Sciences LLC (Inactive) Company Overview 141

5.95 PreMD Inc (Inactive) Company Overview 142

5.96 Protagen AG Company Overview 143

5.97 Protein Alternatives SL Company Overview 144

5.98 Qiagen NV Company Overview 145

5.99 Quest Diagnostics Inc Company Overview 146

5.100 Rabin Medical Center Company Overview 147

5.101 Rhythm Biosciences Ltd Company Overview 148

5.102 RISE Life Science Corp Company Overview 149

5.103 Rna Diagnostics Inc Company Overview 150

5.104 Rosetta Genomics Ltd Company Overview 151

5.105 Scienion AG Company Overview 152

5.106 Seegene Inc Company Overview 153

5.107 Shuwen Biotech Co Ltd Company Overview 154

5.108 Sysmex Corp Company Overview 155

5.109 Tel Aviv University Company Overview 156

5.110 The Chinese University of Hong Kong Company Overview 157

5.111 The Walter and Eliza Hall Institute of Medical Research Company Overview 158

5.112 TheraDiag SA Company Overview 159

5.113 Treos Bio Inc Company Overview 161

5.114 Trinity College Dublin Company Overview 162

5.115 Universal Diagnostics SL Company Overview 163

5.116 University of Illinois at Chicago Company Overview 164

5.117 University of Lyon Company Overview 165

5.118 University of Michigan Company Overview 166

5.119 University of Notre Dame Company Overview 167

5.120 University of Pittsburgh Company Overview 168

5.121 University of Texas MD Anderson Cancer Center Company Overview 171

5.122 University of Turku Company Overview 172

5.123 University of Washington Company Overview 173

5.124 University of Wisconsin Madison Company Overview 174

5.125 US Biomarkers Inc Company Overview 175

5.126 vall d hebron institut de Recerca Company Overview 176

5.127 Vanderbilt University Company Overview 178

5.128 Viomics Inc. Company Overview 180

5.129 VolitionRX Ltd Company Overview 181

5.130 XEPTAGEN SpA Company Overview 191

6 Colorectal Cancer Diagnostic Tests-Recent Developments 192

6.1 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 192

6.2 Jun 29, 2018: GeneNews Announces Directors Election 192

6.3 Jun 21, 2018: 2cureX presents positive clinical data from its IndiTreat CRC trial at ESMO in Barcelona 193

6.4 Jun 21, 2018: Rhythm Biosciences completes cloning step of key reagent development ahead of schedule 193

6.5 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 194

6.6 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 195

6.7 Jun 19, 2018: Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer 195

6.8 Jun 19, 2018: Polymedco Announces Updated American Cancer Society Guidelines for Colorectal Cancer Screening 196

6.9 Jun 13, 2018: Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals 197

6.10 Jun 13, 2018: Vermillion Appoints Chris Goulart As Senior Vice President Of Commercial Operations 198

6.11 Jun 12, 2018: OGT expands custom NGS cancer panel content 198

6.12 Jun 07, 2018: CENTOGENE Partners with the Universities of Greifswald and Rostock to Develop Fast-Tracked Diagnostic Workflow for Personalized Immune-based Therapies for Colon and Pancreatic Tumors 199

6.13 Jun 05, 2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors 199

6.14 Jun 01, 2018: Gopath Labs Announces North American Launch of MiR-31-3p Expression Test 200

6.15 Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 200

7 Appendix 399

7.1 Methodology 399

7.2 About GlobalData 402

7.3 Contact Us 402

7.4 Disclaimer 402


List Of Figure

1.2 List of Figures

Figure 1: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 22

Figure 2: Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 23

Figure 3: Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 24

Figure 4: Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 25

Figure 5: Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 26


List Of Table

1.1 List of Tables

Table 1: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 22

Table 2: Colorectal Cancer Diagnostic Tests-Pipeline Products by Territory 23

Table 3: Colorectal Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 24

Table 4: Colorectal Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 25

Table 5: Colorectal Cancer Diagnostic Tests-Ongoing Clinical Trials 26

Table 6: Colorectal Cancer Companies-Pipeline Products by Stage of Development 27

Table 7: Colorectal Cancer Diagnostic Tests-Pipeline Products by Stage of Development 32

Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview 36

Table 9: IndiTreat-CRC-Product Status 36

Table 10: IndiTreat-CRC-Product Description 36

Table 11: 2cureX AB-Ongoing Clinical Trials Overview 37

Table 12: IndiTreat-CRC-Clinical Evaluation of IndiTreat test for Patients with Stage IV Colorectal Cancer 38

Table 13: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 14: Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 39

Table 15: Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 39

Table 16: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 40

Table 17: ColoFast-Product Status 40

Table 18: ColoFast-Product Description 40

Table 19: Advpharma Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 20: Molecular Diagnostic Biomarker-Colorectal Cancer Diagnostic Tests-Product Status 41

Table 21: Molecular Diagnostic Biomarker-Colorectal Cancer Diagnostic Tests-Product Description 41

Table 22: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

Table 23: DNA Damage Response Deficiency Assay-Colorectal Cancer Diagnostic Tests-Product Status 42

Table 24: DNA Damage Response Deficiency Assay-Colorectal Cancer Diagnostic Tests-Product Description 42

Table 25: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 26: Veracode-Colorectal Cancer Diagnostic Tests-Product Status 43

Table 27: Veracode-Colorectal Cancer Diagnostic Tests-Product Description 43

Table 28: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 29: Parsortix-Based Test-Colorectal Cancer Diagnostic Tests-Product Status 44

Table 30: Parsortix-Based Test-Colorectal Cancer Diagnostic Tests-Product Description 44

Table 31: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 32: SimpliPro Colon-A-Product Status 45

Table 33: SimpliPro Colon-A-Product Description 45

Table 34: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 46

Table 35: Biomarker Test-Colorectal Cancer Diagnostic Tests-Product Status 46

Table 36: Biomarker Test-Colorectal Cancer Diagnostic Tests-Product Description 46

Table 37: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 47

Table 38: ArtemixRx Prognostic Test-Colon Cancer-Product Status 47

Table 39: ArtemixRx Prognostic Test-Colon Cancer-Product Description 47

Table 40: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 41: TheraLink Assay-Colorectal Cancer Diagnostic Tests-Product Status 48

Table 42: TheraLink Assay-Colorectal Cancer Diagnostic Tests-Product Description 48

Table 43: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Table 44: Diagnostic Test-Colorectal Adenoma-Product Status 49

Table 45: Diagnostic Test-Colorectal Adenoma-Product Description 49

Table 46: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Table 47: VeriStrat-Colorectal Cancer Diagnostic Tests-Product Status 50

Table 48: VeriStrat-Colorectal Cancer Diagnostic Tests-Product Description 50

Table 49: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 50: mCRC-Strat-Product Status 51

Table 51: mCRC-Strat-Product Description 51

Table 52: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

Table 53: Metabolomics-based Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 52

Table 54: Metabolomics-based Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 52

Table 55: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 53

Table 56: Ex Vivo Biomarker Test-Colon Cancer-Product Status 53

Table 57: Ex Vivo Biomarker Test-Colon Cancer-Product Description 53

Table 58: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 54

Table 59: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Status 54

Table 60: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Description 54

Table 61: Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Table 62: CyPath Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Status 55

Table 63: CyPath Diagnostic Assay-Colorectal Cancer Diagnostic Tests-Product Description 55

Table 64: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 56

Table 65: MBDAA Colorectal Cancer Test-Product Status 56

Table 66: MBDAA Colorectal Cancer Test-Product Description 56

Table 67: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 57

Table 68: Diagnostic Test-Colon Cancer-Product Status 57

Table 69: Diagnostic Test-Colon Cancer-Product Description 57

Table 70: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 71: PanC-Dx-Colon Cancer-Product Status 58

Table 72: PanC-Dx-Colon Cancer-Product Description 58

Table 73: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Table 74: C-Test-Colorectal Cancer Diagnostic Tests-Product Status 59

Table 75: C-Test-Colorectal Cancer Diagnostic Tests-Product Description 59

Table 76: Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Table 77: DecisionDx-Rectal Cancer-Product Status 60

Table 78: DecisionDx-Rectal Cancer-Product Description 60

Table 79: Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview 61

Table 80: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Status 61

Table 81: Diagnostic Test-Colorectal Cancer Diagnostic Tests-Product Description 61

Table 82: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview 62

Table 83: CELx Test-Colon Cancer-Product Status 62

Table 84: CELx Test-Colon Cancer-Product Description 62

Table 85: CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 86: CellMax Monitor-Colorectal Cancer Diagnostic Tests-Product Status 63

Table 87: CellMax Monitor-Colorectal Cancer Diagnostic Tests-Product Description 63

Table 88: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Table 89: MK-ELISA Assay-Colorectal Cancer Diagnostic Tests-Product Status 64

Table 90: MK-ELISA Assay-Colorectal Cancer Diagnostic Tests-Product Description 64

Table 91: MK-ELISA Assay-Metastatic Colorectal Cancer Diagnostic Tests-Product Status 65

Table 92: MK-ELISA Assay-Metastatic Colorectal Cancer Diagnostic Tests-Product Description 65

Table 93: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Table 94: Nanotrap Colon Cancer Biomarker Test-Product Status 66

Table 95: Nanotrap Colon Cancer Biomarker Test-Product Description 66

Table 96: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Table 97: TissueCypher Colon Cancer Test-Product Status 67

Table 98: TissueCypher Colon Cancer Test-Product Description 67

Table 99: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 68

Table 100: Raman Assay-Colorectal Cancer Diagnostic Tests-Product Status 68

Table 101: Raman Assay-Colorectal Cancer Diagnostic Tests-Product Description 68

Table 102: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Table 103: Diagnostic Kit-Rectum Cancer-Product Status 69

Table 104: Diagnostic Kit-Rectum Cancer-Product Description 69

Table 105: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 70

Table 106: IGFBP-3 Diagnostic Test-Product Status 70

Table 107: IGFBP-3 Diagnostic Test-Product Description 70

Table 108: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

Table 109: caPCNA Test-Colorectal Cancer Diagnostic Tests-Product Status 71

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

2cureX AB, IndiTreat - CRC; Abcodia Ltd, Diagnostic Assay - Colorectal Cancer; Advanced Marker Discovery SL, ColoFast; Advpharma Inc, Molecular Diagnostic Biomarker - Colorectal Cancer; Almac Diagnostics Ltd, DNA Damage Response Deficiency Assay - Colorectal Cancer; Ambergen Inc, Veracode - Colorectal Cancer; ANGLE plc, Parsortix-Based Test - Colorectal Cancer; Applied Proteomics Inc, SimpliPro Colon-A; Arizona State University, Biomarker Test - Colorectal Cancer; ArtemixRx, ArtemixRx Prognostic Test - Colon Cancer; Avant Diagnostics, Inc., TheraLink Assay - Colorectal Cancer; Bio Mark Ltd, Diagnostic Test - Colorectal Adenoma; Biodesix Inc, VeriStrat - Colorectal Cancer; BioMarCare Technologies Ltd, mCRC-Strat; BioMark Diagnostics Inc., Metabolomics-based Diagnostic Assay - Colorectal Cancer; BioMarker Strategies LLC, Ex Vivo Biomarker Test - Colon Cancer; bioMerieux SA, Diagnostic Test - Colorectal Cancer; Biomoda Inc, CyPath Diagnostic Assay - Colorectal Cancer; Bioprognos SL, MBDAA Colorectal Cancer Test; BioSystems International, Diagnostic Test - Colon Cancer; BioTime Inc, PanC-Dx - Colon Cancer; Biotron Ltd, C-Test - Colorectal Cancer; Castle Biosciences Inc, DecisionDx - Rectal Cancer; Catholic University of Leuven, Diagnostic Test - Colorectal Cancer; Celcuity LLC, CELx Test - Colon Cancer; CellMax Life Inc, CellMax Monitor - Colorectal Cancer; Cellmid Ltd, MK-ELISA Assay - Colorectal Cancer; Cellmid Ltd, MK-ELISA Assay - Metastatic Colorectal Cancer; Ceres Nanosciences Inc, Nanotrap Colon Cancer Biomarker Test; Cernostics Inc, TissueCypher Colon Cancer Test; ChemImage Corp, Raman Assay - Colorectal Cancer; China Sky One Medical Inc, Diagnostic Kit - Rectum Cancer; Columbia University, IGFBP-3 Diagnostic Test; CS-Keys, Inc. (Inactive), caPCNA Test - Colorectal Cancer; Di.V.A.L Toscana srl , NanoMabKv - Colorectal Cancer; DiagnoCure Inc. (Inactive), Colorectal/GCC Monitoring Test; DiagnoCure Inc. (Inactive), Colorectal/Shc Prognostic Test; Diaxonhit SA, EHT Dx 12; Diazyme Laboratories Inc, TRAIL-R2 Assay; DNAlytics, ColonoKit; EDP Biotech Corporation, ColoMarker Assay; Epigenomics AG, Diagnostic Test - Colorectal Cancer; Epigenomics AG, Epi proColon 1.0; Eventus Diagnostics Inc (Inactive), Octava Test - Colon Cancer; Exact Sciences Corp, PreGen-Plus; Exiqon A/S, Colon Cancer Test - Stage III And IV Patient; Exosomics Siena SpA, ExoTEST Colorectal; Fina Biotech SL, Dx Bioenergetic Signature - Colon Cancer; Fox Chase Cancer Center, Prognostic Marker - Colorectal Cancer; GenomicTree Inc, EarlyTect Colon Cancer; GenomicTree Inc, EarlyTect Colorectal Cancer - Recurrence; German Cancer Research Center, Autoantibody Panel - Colorectal Cancer; German Cancer Research Center, Biomarker Panel - Colorectal Cancer; Ghent University, Biomarker Test - Colorectal Cancer; GlycoZym, Diagnostic Assay - Colon Cancer; Health Discovery Corp, Diagnostic Test - Colon Cancer; Hitachi Ltd, Urine Based Diagnostic Test - Colon Cancer; Human Metabolome Technologies Inc, Biomarker Based Assay - Colorectal Cancer; Ikonisys Inc, oncoFISH colorectal; Institute of Molecular and Translational Medicine, Diagnostic Biomarker - Colorectal Cancer; InterGenetics Inc, OncoVue Colon; IV Diagnostics Inc, Diagnostic Assay - Colon Cancer; Johns Hopkins University, 5hmC Based Diagnostic Tool - Cancer; Johns Hopkins University, mRNA Biomarker - Colon Cancer; Johns Hopkins University, Prognosis Test - Colorectal Cancer; King Abdullah University of Science and Technology, Diagnostic Test - Colorectal Cancer; Kyo Diagnostics KK, Diagnostic Test - Colorectal Cancer; Lab21 Ltd, Onconostica; Laboratorios Alpha San Ignacio Pharma S.L., OncoSafe; Leitat Technological Center, ELISA Kit - S100A4 - Colon Cancer; Leitat Technological Center, ELISA Kit - S100P - Colon Cancer; Lightsphere Diagnostics, RACC Test - Colorectal Cancer; MabCure Inc., Diagnostic Test - Colorectal Cancer; Master Diagnostica Sociedad Limitada, KRAS / NRAS / BRAF Mutation Flow Chip Test - Colon Cancer; Matrix-Bio, Inc., Companion Diagnostic Test - Colon Cancer; Matrix-Bio, Inc., VeraMarker CCM Test; Matrix-Bio, Inc., VeraMarker CCS Test; Max Delbruck Center for Molecular Medicine, Companion Diagnostic Assay - Colorectal Cancer; Mayo Clinic, Blood Test - Colon Cancer; MDNA Life Sciences Inc, Diagnostic Test - Colorectal Cancer; MDxHealth SA, InformMDx - Colon Cancer; MDxHealth SA, PredictMDx - Colon Cancer; Merrimack Pharmaceuticals Inc, MM-151 Companion Diagnostic Assay - Colorectal Cancer; Metabiomics Corporation, Microbiome Biomarker Screening Test - Colorectal Cancer; Metabiomics Corporation, Microbiome Biomarker Screening Test - Precancerous Colon Polyps; Metabolon Inc, Diagnostic Test - Colorectal Cancer; MetaStat Inc, MenaCalc Colorectal; Milagen Inc, Immunoassay - Colon Cancer; Myriad Genetics Inc, Diagnostic Test - Colon Cancer; Nanocytomics LLC, Minimally Intrusive Fecal Test - Colorectal Cancer; Natera Inc, Signatera - Colorectal Cancer; Norda ASA, Genefec III; Novel Bio-spectrum Technologies Inc (Inactive), NBT Diagnostic Test - Colon Cancer; Nuclea Biotechnologies Inc. (Inactive), Colon Cancer Recurrence Diagnostic Test; Oncimmune (USA) LLC, EarlyCDT - Colon Cancer; Onconome, Inc. (Inactive), ColoMark CCSA-4 Serum Assay; OncoStem Diagnostics Pvt. Ltd, CanAssist - Colon Cancer; On-Q-ity, Inc. (Inactive), Dual-Capture Microfluidic Chip - Colon Cancer; Origin Sciences Ltd, CRC Test; Orion Genomics LLC, Orion CRC Risk Test; OTraces Inc., Colon Cancer Sera Dx; Oxford Cancer Biomarkers Ltd, ColoNav; Oxford Gene Technology Ltd, Diagnostic Assay - Colorectal Cancer; PleX Diagnostics Inc (Inactive), Diagnostic Assay - Colorectal Cancer; Precision Biologics Inc, Diagnostic Assay - Colorectal Cancer; Prediction Sciences LLC (Inactive), GeneRx Colorectal Cancer Profile; PreMD Inc (Inactive), Colopath/ColorectAlert; Protagen AG, Diagnostic Assay - Colon Cancer; Protein Alternatives SL, Colorectal Cancer Diagnostic Kit; Qiagen NV, Blood Based Test - Colorectal Cancer; Quest Diagnostics Inc, Diagnostic Assay - Colorectal Cancer; Rabin Medical Center, Diagnostic Test - Colon Cancer; Rhythm Biosciences Ltd, ColoSTAT; RISE Life Science Corp, Diagnostic Test - Colorectal Cancer; Rna Diagnostics Inc, RNA Disruption Assay - Rectal Cancer; Rosetta Genomics Ltd, miRscreen Test - Colon Cancer; Scienion AG, Diagnostic Test - Colon Cancer; Seegene Inc, MDx - Colon Cancer; Shuwen Biotech Co Ltd, Colorectal Cancer Theranostic Test; Sysmex Corp, Methylated DNA Colon Cancer Diagnostic Test; Tel Aviv University, Biomarker-Based Diagnostic Kit - Colorectal Cancer; The Chinese University of Hong Kong, Colorectal Cancer Screening Tool; The Walter and Eliza Hall Institute of Medical Research, Blood-Based Screening Test - Colon Cancer; TheraDiag SA, Non-invasive Theranostics Test - Metastatic Recurrence; TheraDiag SA, Non-invasive Theranostics Test - Radiochemotherapy; Treos Bio Inc, PolyPEPI 1015 CDx; Trinity College Dublin, Biomarker Test - Colorectal Cancer; Universal Diagnostics SL, Blood Based Diagnostic Test - Colorectal Cancer; University of Illinois at Chicago, Diagnostic Test - Colorectal Cancer; University of Lyon, Biomarker Prognostic Test - Colon Cancer; University of Michigan, Peptide Biomarker Test - Colorectal Cancer; University of Notre Dame, Biomarker Test - Colon Cancer; University of Pittsburgh, Biomarker Test - Colorectal Cancer; University of Texas MD Anderson Cancer Center, Biomarker Based Assay - Colorectal Neoplasia; University of Turku, Lectin-Nanoparticle Biomarker - Colorectal Cancer; University of Washington, Biomarker - Colon Cancer; University of Wisconsin Madison, Diagnostic Kit - Colon Cancer; US Biomarkers Inc, Blood-Based Biomarker - Colorectal Cancer; vall d hebron institut de Recerca , Aprataxin Biomarker - Colorectal Cancer; vall d hebron institut de Recerca , Companion Diagnostic Assay - Colon Cancer; Vanderbilt University, Diagnostic Test - High-Risk Stage II Colorectal Cancer; Vanderbilt University, VICC Blood-Based Diagnostic Test - Colorectal Cancer; Viomics Inc., Viomics Diagnostic Assay - Colon Cancer; VolitionRX Ltd, Nu.Q CRC Screening Test; VolitionRX Ltd, Nu.Q CRC Symptomatic Test; VolitionRX Ltd, Nu.Q CRC Triage Test; VolitionRX Ltd, Nu.Q Frontline Asymptomatic CRC Screening Test; VolitionRX Ltd, NuQ T003 Assay - Colorectal Cancer; VolitionRX Ltd, NuQ V001 Assay - Colorectal Cancer; VolitionRX Ltd, NuQ X001S Assay - Colorectal Cancer; XEPTAGEN SpA, CA19.9 - IgM Kit


Companies

2cureX AB

Abcodia Ltd

Advanced Marker Discovery SL

Advpharma Inc

Almac Diagnostics Ltd

Ambergen Inc

ANGLE plc

Applied Proteomics Inc

Arizona State University

ArtemixRx

Avant Diagnostics, Inc.

Bio Mark Ltd

Biodesix Inc

BioMarCare Technologies Ltd

BioMark Diagnostics Inc.

BioMarker Strategies LLC

bioMerieux SA

Biomoda Inc

Bioprognos SL

BioSystems International

BioTime Inc

Biotron Ltd

Castle Biosciences Inc

Catholic University of Leuven

Celcuity LLC

CellMax Life Inc

Cellmid Ltd

Ceres Nanosciences Inc

Cernostics Inc

ChemImage Corp

China Sky One Medical Inc

Columbia University

CS-Keys, Inc.

Di.V.A.L Toscana srl

DiagnoCure Inc.

Diaxonhit SA

Diazyme Laboratories Inc

DNAlytics

EDP Biotech Corporation

Epigenomics AG

Eventus Diagnostics Inc

Exact Sciences Corp

Exiqon A/S

Exosomics Siena SpA

Fina Biotech SL

Fox Chase Cancer Center

GenomicTree Inc

German Cancer Research Center

Ghent University

GlycoZym

Health Discovery Corp

Hitachi Ltd

Human Metabolome Technologies Inc

Ikonisys Inc

Institute of Molecular and Translational Medicine

InterGenetics Inc

IV Diagnostics Inc

Johns Hopkins University

King Abdullah University of Science and Technology

Kyo Diagnostics KK

Lab21 Ltd

Laboratorios Alpha San Ignacio Pharma S.L.

Leitat Technological Center

Lightsphere Diagnostics

MabCure Inc.

Master Diagnostica Sociedad Limitada

Matrix-Bio, Inc.

Max Delbruck Center for Molecular Medicine

Mayo Clinic

MDNA Life Sciences Inc

MDxHealth SA

Merrimack Pharmaceuticals Inc

Metabiomics Corporation

Metabolon Inc

MetaStat Inc

Milagen Inc

Myriad Genetics Inc

Nanocytomics LLC

Natera Inc

Norda ASA

Novel Bio-spectrum Technologies Inc

Nuclea Biotechnologies Inc.

Oncimmune (USA) LLC

Onconome, Inc.

OncoStem Diagnostics Pvt. Ltd

On-Q-ity, Inc.

Origin Sciences Ltd

Orion Genomics LLC

OTraces Inc.

Oxford Cancer Biomarkers Ltd

Oxford Gene Technology Ltd

PleX Diagnostics Inc

Precision Biologics Inc

Prediction Sciences LLC

PreMD Inc

Protagen AG

Protein Alternatives SL

Qiagen NV

Quest Diagnostics Inc

Rabin Medical Center

Rhythm Biosciences Ltd

RISE Life Science Corp

Rna Diagnostics Inc

Rosetta Genomics Ltd

Scienion AG

Seegene Inc

Shuwen Biotech Co Ltd

Sysmex Corp

Tel Aviv University

The Chinese University of Hong Kong

The Walter and Eliza Hall Institute of Medical Research

TheraDiag SA

Treos Bio Inc

Trinity College Dublin

Universal Diagnostics SL

University of Illinois at Chicago

University of Lyon

University of Michigan

University of Notre Dame

University of Pittsburgh

University of Texas MD Anderson Cancer Center

University of Turku

University of Washington

University of Wisconsin Madison

US Biomarkers Inc

vall d hebron institut de Recerca

Vanderbilt University

Viomics Inc.

VolitionRX Ltd

XEPTAGEN SpA